Background: We established for the first time the prevalence of Chlamydia trachomatis infection among infertile women in Manaus Amazonas Brazil using the polymerase chain reaction (PCR) technique. Methods: 106 women were studied at a public university hospital fertility clinic for infertility problems correlated with chlamydia infection. Social-economic and clinical information was obtained before medical examination to obtain samples for the amplification of C. trachomatis DNA plasmid. Results: The prevalence of chlamydial infection among infertile women was 52.8, and 51.8% of the positive participants were older than 30 years of age (p = 0.8697). Of the 56 women positive for C. trachomatis, 31 (55.4%) had never given birth, while 9 (16%) had a pregnancy resulting in fetal death. Our findings also revealed that these patients had a low socio-economic status and high unemployment (p = 0.0274), and a significant association of 5% (p < 0.05) of chlamydial infection with family income. Conclusions: Due to the high prevalence of C. trachomatis, concerns about effects on reproductive health and fertility are undertaken. Therefore, we believe it is extremely necessary to implement large-scale PCR-based screening as part of routine clinical detection programs concerning preventive effects of chlamydial infection among this population.

Keywords:
Chlamydia trachomatis, Infertile women, Polymerase chain reaction, Brazil
1.
World Health Organization: Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. Geneva, WHO, 2001.
2.
Manavi K: A review on infection with Chlamydia trachomatis. Best Pract Res Clin Obstet Gynaecol 2006;20:941–951.
3.
Chernesky MA: The laboratory diagnosis of Chlamydia trachomatis infections. Can J Infect Dis Med Microbiol 2005;16:39–44.
4.
Polisseni F, Bambirra EA, Camargos AF: Detection of chronic endometritis by diagnostic hysteroscopy in asymptomatic infertile patients. Gynecol Obstet Invest 2003;55:205–210.
5.
Centers for Diseases Control and Prevention: Chlamydia screening among sexually active young female enrollees of health plans – United States, 1999–2001. MMWR Morb Mortal Wkly Rep 2004;53:983–985.
6.
Manual de Controle das Doenças Sexualmente Transmissíveis (DST), ed 3. Brasília, Coordenação Nacional de DST/AIDS 1999. http://www.aids.gov.br/assistencia/mandst99/mandst99.htm (accessed 15/07/ 2008).
7.
Sardinha JCG, Santos AR, Segadilha DAC: In Plano Interinstitucional das DST e AIDS no Estado do Amazonas, 1999.
8.
Ministério da Saúde: Secretaria de Vigilância em Saúde. Programa Nacional de DST e AIDS. Plano Estratégico. Brasília, Ministério da Saúde, 2005.
9.
Benzaken AS, Garcia EG, Sardinha JCG, Pedrosa VL, Paiva V: Community-based intervention to control STD/AIDS in the Amazon region, Brazil. Rev Saúde Pública 2007;41(suppl 2):1–8.
10.
Miranda AE, Szwarcwald CL, Peres RL, Page-Shafer K: Prevalence and risk behaviors for chlamydial infection in a population-based study of female adolescents in Brazil. Sex Transm Dis 2004;31:542–546.
11.
De Codes S, Cohen DA, de Melo NA, Teixeira GG, Leal AS, Silva TJ, de Oliveira MPR: Screening of sexually transmitted diseases in clinical and non-clinical settings in Salvador, Bahia, Brazil. Cad Saude Publica 2006;22:325–334.
12.
Lima HE, Oliveira MB, Valente BG, Afonso DAF, da Rocha WD, Souza MCM, Alvim TC, Barbosa-Stancioli EF, Noronha FSM: Genotyping of Chlamydia trachomatis from endocervical specimens in Brazil. Sex Transm Dis 2007;34:709–717.
13.
Ishak MOG, Ishak R: O impacto da infecção por Chlamydia em populações indígenas da Amazônia Brasileira. Cad Saúde Pública 2000;2:385–396.
14.
Alencar AAF, Ferreira LCL, Loureiro JAS: Detecção de Chlamydia trachomatis por imunoflorescência direta em esfregaços endocervicais. J Bras Ginecol 1993;103:199–203.
15.
Santos C, Teixeira F, Vicente A, Astolfi-Filho S: Detection of Chlamydia trachomatis in endocervical smears of sexually active women in Manaus/AM, by PCR. Braz J Infect Dis 2003;2:91–95.
16.
Brazilian Institute of Geography and Statistics (IBGE): Censos Demográficos e Contagem Populacional; para os anos intercensitários, estimativas preliminares dos totais populacionais, estratificadas por idade e sexo pelo MS/SE/Datasus; in População Residente por Sexo segundo Município. Microrregião: AM Manaus. Sexo: Feminino, 2006.
17.
Hamdad F, Orfila J, Boulanger JC, Eb F: Chlamydia trachomatis urogenital infections in women. Best diagnosis approaches. Gynecol Obstet Fertil 2004;32:1064–1074.
18.
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389–3402.
19.
Paavonen J, Eggert-Kruse W: Chlamydia trachomatis: impact on human reproduction. Hum Reprod Update 1999;5:433–447.
20.
Puolakkainen M, Hiltunen-Back E, Reunala T, Suhonen S, Lähteenmäki P, Lehtinen M, Paavonen J: Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection. J Clin Microbiol 1998;36:1489–1493.
21.
Van Dyck E, Leven M, Pattyn S, Van Damme L, Laga M: Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture and three nucleic acid amplification tests. J Clin Microbiol 2001;39:1751–1756.
22.
Dieterle S, Rummel C, Bader LW, Petersen H, Fenner T: Presence of the major outer membrane protein of Chlamydia trachomatis in patients with chronic salpingitis and salpingitis isthmica nodosa with tubal occlusion. Fertil Stertil 1998;70:774–776.
23.
Land JA, Evers JLH: Chlamydia infection and subfertility. Best Pract Res Clin Obstet Gynaecol 2002;16:901–912.
24.
Hu EB, Zheng W, Stassinopoulos A, Lee JE: Increased specific amplification and flexibility of Accuprime™ Taq DNA polymerase high fidelity in PCR. Focus 2003;25:3.
25.
Land JA, Gijsen AP, Evers JLH, Bruggeman CA: Chlamydia trachomatis in subfertile women undergoing uterine instrumentation. Screen or treat? Hum Reprod 2002;3:525–527.
26.
McWilliams N: Psychoanalytic Diagnosis: Understanding Personality Structure in the Clinical Process. New York, Guildford Press, 1999.
27.
Ginige S, Fairley CK, Hocking JS, Bowden FJ, Chen MY: Interventions for increasing chlamydia screening in primary care: a review. BMC Public Health 2007;7:95.
28.
Jha R, Vardhan H, Bas S, Salhan S, Mittal A: Cervical epithelial cells from Chlamydia trachomatis-infected sites coexpress higher levels of chlamydial heat shock proteins 60 and 10 in infertile women than in fertile women. Gynecol Obstet Invest 2009;68:160–166.
29.
Coste J, Laumon B, Brémond A, Collet P, Job-Spira N: Sexually transmitted diseases as major causes of ectopic pregnancy: results from a large case-control study in France. Fertil Steril 1994;62:289–295.
30.
Ministério da Saúde: Secretaria de Vigilância em Saúde. Manual de Controle Doenças Sexualmente Transmissíveis (DST); in Série Manuais, ed 4. Brasília, Ministério da Saúde, 2006,
31.
Penney GC, Thomson M, Norman J, McKenzie H, Vale L, Smith R, Imrie M: A randomised comparison of strategies for reducing infective complications of induced abortion. BJOG 1998;105:599–604.
32.
Mardh PA: Influence of infection with Chlamydia trachomatis on pregnancy outcome, infant health and life-long sequelae in infected offspring. Best Pract Res Clin Obstet Gynaecol 2002;16:847–864.
33.
Yoshida H, Yamada H, Wada S, Sagawa T, Sakuragi N, Fujimoto S: Reversal of intra-amniotic Chlamydia trachomatis antigen status. Gynecol Obstet Invest 2000;50:278–280.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.